Acid‐Responsive Disassembly of Nanomedicines for Extracellular Drug Delivery Reversing Glioblastoma Immunosuppressive Microenvironment by Targeting the Adenosine‐A2AR Pathway
Small · 2025
DOI: 10.1002/smll.202411689 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Wanxian Lin und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, P. R. China. Hauptthemen laut MEDLINE: Glioblastoma, Tumor Microenvironment, Drug Delivery Systems, Nanomedicine. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangdong Natural Science Foundation, Guangdong Basic and Applied Basic Research Foundation.
Abstract (Originalsprache)
The efficacy of checkpoint blockade immunotherapy for glioblastoma (GBM) is significantly influenced by the precise delivery of therapeutic agents that can penetrate the blood‐brain barrier (BBB) and reprogram the tumor immune microenvironment. Conventional nanoscale carriers used for delivering immune checkpoint blockers are more likely to be internalized by tumor cells, leading to a loss of drug efficacy. This study presents a phosphatidylcholine (PC)‐coated nanoparticle (PCNP) with an optimized PC ratio on its surface, achieving a balanced surface charge. This surface optimization minimizes nanoparticle‐cell membrane interactions, reducing cellular uptake and thereby enhancing extracellular drug targeting efficacy. The constructed PC shell enabled PCNPs to penetrate the BBB mediated by choline transporters. The PC shell can attenuate interactions between PCNPs and cells, thereby preventing the internalization of PCNPs. Additionally, the poly‐ l ‐histidine core can undergo protonation in the acidic microenvironment, resulting in rapid disintegration of PCNPs and facilitating the quick release of the encapsulated CPI‐444 (an extracellular adenosine receptor blocker) and temozolomide, inducing immunogenic cell death and blocking extracellular adenosine receptors to reverse the immunosuppressive feedback signaling pathway of the adenosinergic axis. This combination therapy has shown a novel therapeutic strategy for extracellular immune checkpoint blockade in GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Second Affiliated Hospital, School of Medicine, South China University of Technology, Guangzhou, 510180, P. R. China.
- School of Medical Equipment, Guangdong Food and Drug Vocational College, Guangzhou, 510520, P. R. China.
- Guangdong Medical University, Zhanjiang, 524023, P. R. China.
- School of Biomedical Sciences and Engineering, South China University of Technology, Guangzhou International Campus, Guangzhou, 511442, P. R. China.
- National Engineering Research Center for Tissue Restoration and Reconstruction, and Guangdong Province Key Laboratory of Biomedical Engineering, South China University of Technology, Guangzhou, 510006, P. R. China.
- Center for Medical Research on Innovation and Translation, Institute of Clinical Medicine, Guangzhou First People's Hospital, The Second Affiliated Hospital, South China University of Technology, Guangzhou, 510180, P. R…
ORCID-Profile: Wanxian Lin, Ruimeng Yang
Förderung
- National Natural Science Foundation of China
- Guangdong Natural Science Foundation
- Guangdong Basic and Applied Basic Research Foundation
- Guangzhou Science and Technology Planning Project
- Medical Science and Technology Research Project of Guangdong Province
- Key Laboratory of Bioorganic Chemistry and Molecular Engineering, Ministry of Education
- Natural Science Foundation of Guangdong Province
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Lin, W., Wei, R., Lai, S., Li, J., Zhao, Y., Lin, J., Zhan, J., Wu, M., Guan, X., Wei, X., Jiang, X., Yang, X., Cao, Z., & Yang, R. (2025). Acid‐Responsive Disassembly of Nanomedicines for Extracellular Drug Delivery Reversing Glioblastoma Immunosuppressive Microenvironment by Targeting the Adenosine‐A2AR Pathway. Small. https://doi.org/10.1002/smll.202411689
Vancouver
Lin W, Wei R, Lai S, Li J, Zhao Y, Lin J, et al. Acid‐Responsive Disassembly of Nanomedicines for Extracellular Drug Delivery Reversing Glioblastoma Immunosuppressive Microenvironment by Targeting the Adenosine‐A2AR Pathway. Small. 2025. doi:10.1002/smll.202411689
BibTeX
@article{Lin2025,
author = {Lin, Wanxian and Wei, Ruili and Lai, Shengsheng and Li, Jiamin and Zhao, Yandong and Lin, Jiaxin and Zhan, Jie and Wu, Mengni and Guan, Xiuhong and Wei, Xinhua and Jiang, Xinqing and Yang, Xianzhu and Cao, Ziyang and Yang, Ruimeng},
title = {Acid‐Responsive Disassembly of Nanomedicines for Extracellular Drug Delivery Reversing Glioblastoma Immunosuppressive Microenvironment by Targeting the Adenosine‐A2AR Pathway},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202411689}
}
EUVIMED